Targeted therapy is not suitable for all cancer patients. Eligibility for targeted therapy depends on specific genetic or molecular changes found in cancer cells, not just the cancer type or stage.
This treatment is recommended only when testing confirms that a tumour has a targetable mutation or marker. This article explains who may be eligible for targeted therapy, what tests are required, and why many patients may not qualify despite having cancer.
What Is Targeted Therapy?
Targeted therapy is a type of cancer treatment designed to act on specific molecules or pathways involved in cancer growth and survival. Unlike chemotherapy, which affects both cancerous and healthy rapidly dividing cells, targeted therapy aims to act more selectively.
However, this selectivity is also its limitation – targeted therapy works only when a suitable target is present.
The Most Important Requirement: A Targetable Mutation or Marker
The single most important factor for eligibility is the presence of a targetable mutation, gene change, or biomarker in the cancer cells.
Targeted therapy is considered only when:
- Molecular or genetic testing identifies a known actionable target
- Approved targeted drugs exist for that specific cancer type and mutation
Without these findings, targeted therapy is unlikely to be effective and is usually not recommended.
Eligibility Criteria for Targeted Therapy
A patient may be considered eligible for targeted therapy when all or most of the following conditions are met:
1. Presence of a Targetable Genetic or Molecular Change
This is confirmed through:
- Biopsy analysis
- Molecular profiling
- Biomarker or mutation testing
Examples include certain mutations seen in lung cancer, breast cancer, colorectal cancer, and other cancers.
2. Cancer Type That Responds to Targeted Drugs
Not all cancers have approved targeted therapies. Eligibility also depends on whether:
- The cancer type has evidence-supported targeted treatment options
- The mutation identified is relevant for that cancer
Even if a mutation is present, targeted therapy may not be effective for all cancer types.
3. Stage and Behaviour of the Cancer
Targeted therapy may be used:
- In advanced or metastatic cancer
- In some early-stage cancers with high-risk features
- When cancer has not responded well to standard treatments
The stage and aggressiveness of the cancer play a role in decision-making.
4. Overall Health and Organ Function
Doctors also consider:
- Liver and kidney function
- Bone marrow reserve
- Other medical conditions
Targeted therapy may not be suitable if side effects could outweigh potential benefits.
5. Previous Treatments and Response
Eligibility is influenced by:
- Treatments already received
- How the cancer responded
- Whether resistance to prior therapy has developed
Targeted therapy may be introduced at diagnosis or later, depending on the case.
Who May NOT Be Eligible for Targeted Therapy?
Targeted therapy is not recommended in several situations.
A patient may not be eligible if:
- No actionable mutation or biomarker is found
- The cancer does not have approved targeted drugs
- The cancer biology suggests low likelihood of response
- Severe organ dysfunction is present
- The patient’s overall condition does not allow safe treatment
This does not mean treatment options are exhausted other approaches may still be effective.
Tests Required to Determine Eligibility
Eligibility for targeted therapy cannot be decided without testing.
Common tests include:
- Tissue biopsy and pathology review
- Molecular profiling or gene mutation testing
- Blood tests in selected cases
These tests help doctors avoid ineffective treatment and unnecessary side effects.
Can Targeted Therapy Be Used Along With Other Treatments?
Yes, in some cases targeted therapy may be:
- Combined with chemotherapy
- Used along with immunotherapy
- Given after surgery or radiation
The sequence and combination depend on cancer type, stage, and response to treatment.
Is Targeted Therapy Always Better Than Chemotherapy?
Not necessarily.
Targeted therapy:
- Is effective only in selected patients
- May cause fewer traditional side effects
- Can still have significant adverse effects
Chemotherapy remains the mainstay treatment for many cancers, especially when no targetable mutation is present.
Side Effects and Monitoring
Although targeted therapy is more selective, it can still cause side effects such as:
- Skin reactions
- Fatigue
- Digestive issues
- Blood pressure changes
Regular monitoring is essential, and treatment may be adjusted if side effects occur.
Why a Specialist Consultation Is Essential
Eligibility for targeted therapy cannot be determined through symptoms or scans alone. A medical oncologist reviews:
- Test results
- Cancer behaviour
- Treatment goals
- Patient preferences
This ensures that targeted therapy is used only when it offers real benefit.
Also refer Which Cancers Respond Best to Immunotherapy?
Important Note for Patients
Targeted therapy is a powerful tool in modern cancer care, but it is not a universal solution. Treatment decisions should always be individualised and based on scientific evidence, not assumptions or trends.
Patients are encouraged to ask questions and understand why a particular treatment is or is not recommended.
Key Takeaway
Targeted therapy is suitable only for cancer patients whose tumours have specific targetable molecular or genetic changes. Eligibility is determined by testing, cancer type, and overall health not by preference alone.
FAQ Section
- Who is eligible for targeted therapy?
Patients whose cancer shows a specific targetable mutation or biomarker on molecular testing may be eligible, depending on cancer type and overall health.- Does every cancer patient qualify for targeted therapy?
No, Targeted therapy works only in cancers with actionable molecular changes and is not suitable for all patients.- Are tests required before starting targeted therapy?
Yes. Biopsy and molecular or genetic testing are essential to determine eligibility.- Can targeted therapy be used with chemotherapy?
In some cases, targeted therapy may be combined with chemotherapy or other treatments, depending on clinical factors.
Final Thoughts
Advances in cancer treatment have expanded options beyond traditional therapies, but choosing the right treatment requires precision. Targeted therapy can be highly effective when used in the right patient, at the right time, for the right cancer.
If targeted therapy has been suggested or is being considered, a detailed discussion with a qualified oncologist can help clarify eligibility and expectations.